Congestive Heart Failure Treatment Devices Market Outlook | Forecast 2022-2030

Latest Research Study on “congestive heart failure treatment devices Market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Region Outlook, And Segment Forecasts, 2021 – 2030”.

The Global congestive heart failure treatment devices market size is expected to reach around US$ 42.0 billion by 2030 and is anticipated to grow at a CAGR of 18.1% during forecast period 2021 to 2030.

Get Sample Copy of This [email protected]

Report Highlights

The Implantable Cardioverter Defibrillators (ICDs) held a lucrative share in the market due to its ability to perform three basic functions, which include defibrillation, cardioversion, and pacing of the heart. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2015, which was followed by the pacemaker’s segment. This can be attributed to the fact that and form the primary line of treatment administered for heart failure. On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs

North America dominated the overall industry in terms of revenue share at over 40.0% in 2020; this can be attributed to the presence of a large population base suffering from cardiovascular disorders coupled with a significant geriatric population base. Asia-Pacific is expected to grow at the fastest CAGR during the forecast period and its share is expected to grow, owing to the increasing demand for these products. Furthermore, the rapidly improving healthcare infrastructure in the countries, such as India and Japan, also contribute toward the growth of this region.

According to the American Heart Association, 17.3 million deaths occur due to cardiovascular disorders, and this number is expected to rise to 23.6 million by 2030. This high prevalence resulted in greater usage of this equipment in this region. In addition, developed healthcare infrastructure in the U.S. facilitated access to advanced therapeutics. This contributed to the growth of this region. Moreover, the availability of reimbursement for cardiovascular therapies supported the growth substantially.

Key Players

Medtronic Plc, Boston Scientific Corporation, Biotronik SE & Co., KG, St. Jude Medical, among others. 

Market Segmentation

  • Global CHF Treatment Devices Market by Product
    • Ventricular Assist Devices (VADs)

      • LVAD

      • RVAD

      • BiVAD

    • Counter Pulsation Devices

    • Implantable Cardioverter Defibrillators

      • Transvenous ICD

      • Subcutaneous ICD

    • Pacemakers

      • Implantable

      • External

    • Cardiac Resynchronization therapy

      • Cardiac Resynchronization Therapy-Defibrillators (CRT-D)

      • Cardiac Resynchronization Therapy-Pacemakers (CRT-P)

  • CHF Treatment Devices Market by Region 
    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Congestive Heart Failure Treatment Devices market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Congestive Heart Failure Treatment Devices industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Leave a Reply

Your email address will not be published.